Skip to main content

Table 5 Prevalence of and average HbA1c values by cumulative number of metabolic syndrome components

From: Sustained metabolic dysregulation and the emergence of diabetes: associations between HbA1c and metabolic syndrome components in Tunisian diabetic and nondiabetic groups

# of MetS Components

 

Women

Men

Diabetic

Nondiabetic

Diabetic

Nondiabetic

0

n

25 (3.6%)

462 (13.4%)

55 (7.8%)

547 (17.6%)

HbA1c M ± SE

7.62 ± 0.32

5.34 ± 0.02

7.87 ± 0.26

5.30 ± 0.02

1

n

63 (9.0%)

915 (26.6%)

116 (16.4%)

997 (32.1%)

HbA1c M ± SE

7.54 ± 0.19

5.41 ± 0.02

7.84 ± 0.16

5.41 ± 0.01

2

n

173 (24.6%)

997 (29.0%)

232 (32.7%)

1031 (33.2%)

HbA1c M ± SE

8.01 ± 0.14

5.44 ± 0.02

8.01 ± 0.13

5.49 ± 0.01

3

n

238 (33.9%)

770 (22.4%)

209 (29.5%)

420 (13.5%)

HbA1c M ± SE

7.83 ± 0.11

5.57 ± 0.02

8.33 ± 0.14

5.55 ± 0.02

4

n

204 (29.0%)

295 (8.6%)

112 (3.6%)

112 (3.6%)

HbA1c M ± SE

8.14 ± 0.13

5.63 ± 0.03

8.37 ± 0.18

5.59 ± 0.04

ρ

 

0.09

0.19

0.12

0.18

p

 

0.02 *

< 2.2e-16 ***

0.002 **

< 2.2e-16 ***

  1. Components determined by values that exceed ATP III Metabolic Syndrome criteria thresholds (Table 1)
  2. * p < 0.05; ** p < 0.01; *** p < 0.001